AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2021

Mar 1, 2021

30016_dirs_2021-03-01_359c51f1-8e7f-4827-8d64-ff383e571b9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-26

Reporting Person: TWIGGE GIOVANI (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-26	Common Stock	M	3227	$67.85	Acquired	16950	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-26	Non-Qualified Stock Option (right-to-buy)	$67.85	M	3227	Disposed	2026-02-13	Common Stock (3227)	Direct

Footnotes

F1: Grant of option to buy 22,028 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2017.

F2: Not applicable.